Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Bhageria Industries Limited (BHAGERIA.NS)
Mumbai, IN
Bhageria Industries Limited, an Indian company headquartered in Mumbai, was founded in 1989. Previously known as Bhageria Dye Chem Limited until its renaming in August 2015, the firm is a key producer and supplier of dyes, dye intermediates, and essential chemicals across India. Diversifying its portfolio, the company is also active in the solar energy sector, involved in power generation and distribution, as well as executing Engineering, Procurement, and Construction (EPC) contracts. Its chemical products are exported globally to a wide range of international markets, including South Korea, Japan, Taiwan, China, Germany, the United States, and various other countries in Europe and Africa.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.83% | -3.55% | -1.10% | -0.64% | -19.01% | -11.30% | -3.93% | +24.99% | -20.86% | +316.03% | +514.62% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Chemicals - Specialty: +4.7%+47.0% ★ Q1'26: +48.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+14.0% ★ Q1'26: -24.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+6.7% ★ Q1'26: -11.1% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+6.7% Q1'26: +8.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+6.3% ★ Q1'26: +8.9% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.11× Q1'26: 0.82× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.44B
est: 3.51B (-1.9%)
|
3.65B
est: 4.57B (-20.3%)
|
4.56B
est: 4.70B (-2.9%)
|
4.11B
est: 4.38B (-6.3%)
|
4.01B
est: 4.87B (-17.6%)
|
5.97B
est: 5.11B (+16.7%)
|
5.01B
est: 5.37B (-6.6%)
|
3.51B
3.51B – 3.51B
-34.6% YoY
|
3.51B
3.51B – 3.51B
+0.0% YoY
|
4.57B
4.57B – 4.57B
+30.3% YoY
|
4.70B
4.70B – 4.70B
+2.7% YoY
|
4.38B
4.38B – 4.38B
-6.7% YoY
|
4.87B
4.87B – 4.87B
+11.0% YoY
|
| EBITDA |
724.82M
est: 599.03M (+21.0%)
|
913.34M
est: 780.55M (+17.0%)
|
1.30B
est: 801.44M (+62.3%)
|
1.03B
est: 748.09M (+37.8%)
|
1.08B
est: 830.37M (+29.9%)
|
1.26B
est: 1.16B (+7.9%)
|
578.78M
est: 921.19M (-37.2%)
|
483.31M
483.31M – 483.31M
-47.5% YoY
|
483.31M
483.31M – 483.31M
+0.0% YoY
|
629.76M
629.76M – 629.76M
+30.3% YoY
|
646.62M
646.62M – 646.62M
+2.7% YoY
|
603.57M
603.57M – 603.57M
-6.7% YoY
|
669.96M
669.96M – 669.96M
+11.0% YoY
|
| EBIT |
661.36M
est: 390.06M (+69.6%)
|
678.15M
est: 508.26M (+33.4%)
|
1.08B
est: 521.87M (+107.0%)
|
802.23M
est: 487.12M (+64.7%)
|
818.90M
est: 540.70M (+51.5%)
|
971.17M
est: 871.97M (+11.4%)
|
233.86M
est: 599.84M (-61.0%)
|
293.24M
293.24M – 293.24M
-51.1% YoY
|
293.24M
293.24M – 293.24M
+0.0% YoY
|
382.10M
382.10M – 382.10M
+30.3% YoY
|
392.33M
392.33M – 392.33M
+2.7% YoY
|
366.21M
366.21M – 366.21M
-6.7% YoY
|
406.49M
406.49M – 406.49M
+11.0% YoY
|
| Net Income |
435.26M
est: 568.10M (-23.4%)
|
403.39M
est: 717.98M (-43.8%)
|
715.06M
est: 776.01M (-7.9%)
|
658.14M
est: 726.49M (-9.4%)
|
626.62M
est: 822.05M (-23.8%)
|
705.97M
est: 767.53M (-8.0%)
|
147.45M
est: 949.40M (-84.5%)
|
568.15M
568.15M – 568.15M
-40.2% YoY
|
568.15M
568.15M – 568.15M
+0.0% YoY
|
718.05M
718.05M – 718.05M
+26.4% YoY
|
776.08M
776.08M – 776.08M
+8.1% YoY
|
726.56M
726.56M – 726.56M
-6.4% YoY
|
822.12M
822.12M – 822.12M
+13.2% YoY
|
| SGA |
101.22M
est: 134.87M (-24.9%)
|
107.56M
est: 175.73M (-38.8%)
|
99.27M
est: 180.44M (-45.0%)
|
94.71M
est: 168.42M (-43.8%)
|
189.15M
est: 186.95M (+1.2%)
|
198.17M
est: 564.76M (-64.9%)
|
204.64M
est: 207.40M (-1.3%)
|
195.64M
195.64M – 195.64M
-5.7% YoY
|
195.64M
195.64M – 195.64M
+0.0% YoY
|
254.92M
254.92M – 254.92M
+30.3% YoY
|
261.75M
261.75M – 261.75M
+2.7% YoY
|
244.32M
244.32M – 244.32M
-6.7% YoY
|
271.20M
271.20M – 271.20M
+11.0% YoY
|
| EPS |
11.52
est: 13.02 (-11.5%)
|
9.24
est: 16.46 (-43.8%)
|
16.38
est: 17.79 (-7.9%)
|
15.08
est: 16.65 (-9.4%)
|
14.36
est: 18.84 (-23.8%)
|
16.17
est: 20.20 (-19.9%)
|
3.38
est: 21.65 (-84.4%)
|
13.02
13.02 – 13.02
-39.9% YoY
|
13.02
13.02 – 13.02
+0.0% YoY
|
16.46
16.46 – 16.46
+26.4% YoY
|
17.79
17.79 – 17.79
+8.1% YoY
|
16.65
16.65 – 16.65
-6.4% YoY
|
18.84
18.84 – 18.84
+13.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Suresh Kumar Keshavdeo Bhageria | Executive Chairman | 11M | male |
| Vikas Suresh Bhageria | Joint MD & Whole Time Director | 9M | male |
| Vinodkumar Keshadev Bhageria | MD & Executive Director | 1M | male |
| Deepa Mahavir Prasad Toshniwal | Whole-Time Company Secretary & Compliance Officer | — | female |
| Rakesh L. Kachhadiya | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BHAGERIA.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
